In this issue, I update the status of our recent Apple Put sale and also of our Goldman Sachs Group trade. Read More
Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Analyst Articles
To determine what's really going on in the housing market, you need to look behind the headlines. Read More
This issue, I update the status of our recent, and already in the money, Apple Put sale, while recommending a new put sale based on shares of Goldman Sachs. Read More
News headlines are focusing on oil prices, but there's a potential storm brewing in the natural gas market. Here's what you need to know. Read More
In this issue, I close out our Merck and Eli Lilly trades and recommend a new position in Apple. Read More
Amid the clutter in the nuclear industry, two huge miners, BHP and Rio Tinto, control uranium properties that are poised for a bull run. Read More
In this issue, I concentrate on managing our two existing trades based on Merck and Eli Lilly. Read More
We show you how you can use short-term trading techniques as a side hustle, without leaving the comfort of your house. Read More
We're offer a new trade based on medical supply company McKesson Corp., and we update our recent trade on Big Pharma firm Eli Lilly. Read More
To succeed over the long term, you need to get a handle on risk. Here's how to tap growth but still avoid unnecessary hazards. Read More